phenobarbital sodium contraindications for Dummies

phenobarbital sodium contraindications for Dummies

Blog Article

pentobarbital will lower the extent or effect of naloxegol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Use of naloxegol with sturdy CYP3A4 inducers is just not encouraged

pentobarbital will minimize the extent or effect of vinorelbine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Not known.

pentobarbital will lessen the level or effect of docetaxel by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Not known.

pentobarbital will decrease the level or effect of linagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on. Utilization of alternative treatment options is strongly recommended when linagliptin will be to be administered with a CYP3A4 inducer

pentobarbital will lessen the extent or effect of avanafil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. For patients with ED, check response very carefully thanks to possible for lowered effectiveness.

pentobarbital will minimize the extent or effect of fentanyl transdermal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Intently. Coadministration of fentanyl with CYP3A4 inducers could lead into a lower in fentanyl read more plasma concentrations, deficiency of efficacy or, potentially, improvement of the withdrawal syndrome within a affected person that has designed Bodily dependence to fentanyl.

pentobarbital will minimize the level or effect of triamcinolone acetonide injectable suspension by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.

pentobarbital will minimize the level or effect of estropipate by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.

pentobarbital will decrease the extent or effect of itraconazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Unfamiliar.

Use in pregnancy: Barbiturates could potentially cause fetal problems when administered to some pregnant girl. Retrospective, situation-controlled research have suggested a link amongst the maternal consumption of barbiturates and the next than predicted incidence of fetal abnormalities. Following oral or parenteral administration, barbiturates conveniently cross the placental barrier and they are distributed throughout fetal tissues with optimum concentrations found in the placenta, fetal liver, and brain.

pentobarbital will minimize the extent or effect of lapatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.

The effect with the resultant diminished blood levels of griseofulvin on therapeutic reaction hasn't been set up. Nevertheless, it would be preferable to stay away from concomitant administration of such drugs.

pentobarbital will minimize the level or effect of tolterodine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.

pentobarbital will minimize the level or effect of alfuzosin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unknown.